Karnataka Health and Medical Education Minister Dr. K Sudhakar visited the Defence Research and Development Organisation (DRDO) yesterday and held interaction on the availability of 2-deoxy D Glucose medicine also known as 2-DG, which has been developed by the DRDO.
The drug is said to deny the Covid virus the energy to multiply. The Minister met DRDO Director Manjula J and sought details on the proposed makeshift hospital and oxygen plant to be set up by the organisation.
The 2-DG drug developed by DRDO could be a game changer in the battle against the pandemic. The clinical trials of this drug have shown that it resulted in faster recovery of Covid critical patients and reduced dependency on oxygen. The Drugs Controller General of India and Central Drugs Standard Control Organisation had permitted the Phase II clinical trial of 2-DG in May last year. During the Phase II trials the drug was found safe helping the Covid patients to recover early. In November last year Phase III clinical trial was permitted. The trials showed that patients improved symptomatically and their dependency on oxygen reduced in three days. On May 1st this year, DCGI granted permission for the emergency use of 2-DG that comes in powder form in sachets and taken orally by dissolving in water. It was found that the drug accumulates in the virus infected cells and prevents the virus from multiplying.